CEO Dave Ricks says Lilly’s weight loss pill, or foragliprone, could get FDA approval in 2026
Eli Lilly & Co., the Fortune 500 pharma firm that makes the weight-loss injection Zepbound (tirzepetide), has a comparable oral ...
Read more
Lilly-funded clinical trial says Zapbound (tirzepetide) superior to Vegovi (semaglutide)
In the midst of the war on obesity, a battle between two weight loss vaccines has emerged as a clear ...
Read more
